Fonar Corp (FONR)
14.55
-0.71
(-4.65%)
USD |
NASDAQ |
Nov 04, 16:00
14.51
-0.04
(-0.27%)
Pre-Market: 20:00
Fonar Shareholders Equity (Quarterly): 165.97M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 165.97M |
March 31, 2024 | 165.76M |
December 31, 2023 | 163.89M |
September 30, 2023 | 161.30M |
June 30, 2023 | 157.91M |
March 31, 2023 | 157.18M |
December 31, 2022 | 154.09M |
September 30, 2022 | 152.22M |
June 30, 2022 | 150.29M |
March 31, 2022 | 148.05M |
December 31, 2021 | 145.76M |
September 30, 2021 | 142.31M |
June 30, 2021 | 138.42M |
March 31, 2021 | 137.70M |
December 31, 2020 | 133.83M |
September 30, 2020 | 128.70M |
June 30, 2020 | 126.19M |
March 31, 2020 | 125.61M |
December 31, 2019 | 124.35M |
September 30, 2019 | 121.25M |
June 30, 2019 | 115.96M |
March 31, 2019 | 111.37M |
December 31, 2018 | 107.50M |
September 30, 2018 | 103.95M |
June 30, 2018 | 98.68M |
Date | Value |
---|---|
March 31, 2018 | 88.83M |
December 31, 2017 | 85.35M |
September 30, 2017 | 81.16M |
June 30, 2017 | 77.44M |
March 31, 2017 | 69.16M |
December 31, 2016 | 62.46M |
September 30, 2016 | 58.20M |
June 30, 2016 | 52.38M |
March 31, 2016 | 47.76M |
December 31, 2015 | 44.75M |
September 30, 2015 | 41.26M |
June 30, 2015 | 38.39M |
March 31, 2015 | 32.66M |
December 31, 2014 | 30.64M |
September 30, 2014 | 27.98M |
June 30, 2014 | 25.31M |
March 31, 2014 | 20.97M |
December 31, 2013 | 18.98M |
September 30, 2013 | 16.68M |
June 30, 2013 | 14.11M |
March 31, 2013 | 9.275M |
December 31, 2012 | 7.945M |
September 30, 2012 | 6.44M |
June 30, 2012 | 5.004M |
March 31, 2012 | 3.376M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
124.35M
Minimum
Dec 2019
165.97M
Maximum
Jun 2024
146.29M
Average
148.05M
Median
Mar 2022
Shareholders Equity (Quarterly) Benchmarks
XWELL Inc | 8.798M |
ProPhase Labs Inc | 44.08M |
Applied DNA Sciences Inc | 12.39M |
Veracyte Inc | 1.133B |
OncoCyte Corp | 22.70M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 214.25M |
Total Liabilities (Quarterly) | 57.46M |
Debt to Equity Ratio | 0.0007 |
Current Ratio | 7.858 |
Net Debt Paydown Yield | 0.01% |